Tavenner Clarifies CMS' Compound Drug Policy Ahead Of Confirmation Vote

It is appropriate for Medicare to pay for compounded drugs if a patient is allergic to inactive ingredients in an FDA-approved product or if a drug is not available in a needed dosage or strength, and CMS is working with FDA to ensure that Medicare payments for compounded drugs that violate the Federal Food, Drug and Cosmetic Act are denied, CMS Acting Administrator Marilyn Tavenner said in response to questions from Senate Finance Committee members ahead of her confirmation vote Tuesday.

source found here